Anticholinergic therapy: do the patients take the pills prescribed?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00404-010-1720-x.pdf
Reference15 articles.
1. Abrams P, Cardozo L, Fall M, Griffiths DJ et al (2002) The standardisation of terminology of lower urinary tract function. Neurourol Urodynam 21:167–178
2. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336
3. Roxburgh C, Cook J, Dublin N (2007) Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev CD003190
4. Abrams P, Freeman RM, Anderstrom C, Mattiasson A (1998) Tolterodine, a new antimuscarinic agent; as effective but better tolerated than oxybutinin in patients with an overactive bladder. Br J Urol 81:801–810
5. Zinner NR, Tuttle J, Marks L (2005) Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutinin in patients with an overactive bladder. World J Urol 23:248–252
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How can we explain the poor medication adherence in patients with overactive bladder syndrome?;Hellenic Urology;2024-07
2. Determining patient preferences in the treatment of medication‐refractory overactive bladder;Neurourology and Urodynamics;2022-12-08
3. Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity;Asian Journal of Urology;2022-09
4. Long-term effectiveness of an intervention to enhance mirabegron use revision and its deprescribing: 36-month follow-up of a quasi-experimental trial in primary care;Current Medical Research and Opinion;2021-02-26
5. A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure;International Neurourology Journal;2019-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3